Promoting Self-Management in Head and Neck Cancer Survivors With Lymphedema and Fibrosis [PROMISE Trial]

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \>18 years of age

• Post HNC primary treatment

• No evidence of cancer (NED)

• Completion of initial lymphedema therapy for head and neck lymphedema

• Unable to obtain lymphedema therapy due to barriers noted above

• History of lymphedema on the face and neck, with or without fibrosis

• Ability to understand English in order to complete questionnaires

• Ability to perform self-care activities for LEF management

• Ability to provide informed consent

• Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home

• A valid email address

Locations
United States
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Tennessee
Barbara Murphy
RECRUITING
Nashville
Contact Information
Primary
Jie Deng, PhD
jiedeng@nursing.upenn.edu
2155732393
Time Frame
Start Date: 2024-03-29
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 204
Treatments
Other: Usual Care
Experimental: In-Person LEF-SMP
Experimental: Telehealth LEF-SMP
Related Therapeutic Areas
Sponsors
Collaborators: United States Department of Defense
Leads: Abramson Cancer Center at Penn Medicine

This content was sourced from clinicaltrials.gov

Similar Clinical Trials